PLAY PODCASTS
203: Value series: Is the future of VBC in specialty care? Zing Health & Strive Health say yes.

203: Value series: Is the future of VBC in specialty care? Zing Health & Strive Health say yes.

In the final episode of our value series, host Rachel Woods invites TJ Ackerman, Senior Vice President of Provider and Network Performance at Zing Health, and later Will Stokes, Chief Strategy Officer at Strive Health, to discuss what good specialty care looks like and why value-based specialty care is the future.

Radio Advisory

April 9, 202432m 27s

Audio is streamed directly from the publisher (aphid.fireside.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Last week, in part two of our series on value-based care, we talked about how CenterWell, Humana’s provider arm, turned to senior-focused primary care to grow their value-based strategy. But as the Medicare Advantage market gets larger, older, and sicker, it is becoming clear that a focus on primary care isn’t enough. The fact is, VBC in specialty care is the future.

In part three of our value series, host Rachel (Rae) Woods invites TJ Ackerman, Senior Vice President of Provider and Network Performance at Zing Health, to discuss what good specialty care in Medicare Advantage looks like. We also talk with one of Zing’s provider partners, Will Stokes, Chief Strategy Officer at Strive Health, a leader in value-based kidney care. Together, TJ and Will discuss the importance of payer-provider partners in value-based specialty care.

Links:


Use the Market Scenario Planner


Learn about Advisory Board On-Demand Courses


Register for the Raising the Value Bar Summit


3 strategies for facing the 'tripledemic' of respiratory viruses


A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

Topics

specialty careC-SNPschronic kidney diseaseMedicare Advantage